(State or other jurisdiction | (IRS Employer | |||||||
of incorporation or organization) | Identification No.) |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Emerging growth company |
Nominee | For | Withheld | ||||||
Richard M. Ashworth | 28,843,954 | 291,449 | ||||||
Vickie L. Capps | 28,530,632 | 604,771 | ||||||
Molly J. Coye, MD | 27,497,790 | 1,637,613 | ||||||
Julie D. Klapstein | 27,400,427 | 1,734,976 | ||||||
Teresa L. Kline | 28,350,393 | 785,010 | ||||||
Paul B. Kusserow | 28,352,829 | 782,574 | ||||||
Bruce D. Perkins | 28,767,548 | 367,855 | ||||||
Jeffrey A. Rideout, MD | 28,534,512 | 600,891 | ||||||
Ivanetta Davis Samuels | 28,585,947 | 549,456 |
For | Against | Abstain | ||||||
29,134,996 | 1,030,677 | 9,020 |
For | Against | Abstain | ||||||
25,585,302 | 3,529,623 | 20,478 |
One Year | Two Years | Three Years | Abstain | ||||||||
28,501,033 | 6,372 | 617,416 | 10,582 |
Cover Document |
Jun. 08, 2023 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Document Period End Date | Jun. 08, 2023 |
Entity File Number | 0-24260 |
Entity Registrant Name | AMEDISYS INC |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 11-3131700 |
Entity Address, Street | 3854 American Way |
Entity Address, Suite | Suite A |
Entity Address, City | Baton Rouge |
Entity Address, State | LA |
Entity Address, Postal Zip Code | 70816 |
City Area Code | 225 |
Local Phone Number | 292-2031 |
Title of each class | Common Stock, par value $0.001 per share |
Trading Symbol | AMED |
Name of each exchange on which registered | NASDAQ |
Entity Emerging Growth Company | false |
Entity Central Index Key | 0000896262 |
Amendment Flag | false |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
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end
*MJ:("B&J*9BJ:)BL81-L6YA5X!6-
MLSC:;3>&^<$<_:@X,D+7^9KKQG&_>'@X' X+]$XA"#N'/,L*AXX?Q=@W22Y]
M?^[-H9"\QVF:=CBB;4Y?*KJ.?_=$F_2Q@:-9FT5G%#,1,>>^@.M")[B'_N%M
M0N%^&(?8CRA8<0QX@:8XB6%51N!F[8PB9]7XH$_N\#_ZV:79)1YF%F9$>U\]
MUJ>ZYEF&Y1F.GS5BD8>NDP9FXX<']'7^H;=U@.&$1SW^G-(2*.> 3I\FKQ9=
M['>^YHC/7%WF ,$$6T=?/!)C1#]ER'\'SOW7W''@QT"X3'/=PG*80
M2>-Y"5NB(F,-.A5XDS=L7P+K9SRM:@@]^Q$-9OIQ:LJEI=C3
MHY&MGZ4RZ=UO 2T4!!?EG[42IT^.'\YG>:B;Z?@KC6NP#4=CF"6.TW.79]'2
M^?J?:;5.N'T_K7^;Q&OG[/_U94-7#+2;'!U#BSHFI\< \!S?= <6F7,=/.I@
MVO%:&,[/[J_9O#R8%C7PHSD@-^G),'U@<>88@.RZ & /%!_:"#!<:CC3.O1N
MTJ(/ZV/E0)*0?5;3ZS+5EFM2K6MV"2B#DL;L7J!49FT0HLE;];
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M52SD+A$"X9";CY[+ 42AKV/9]R3$G(-&U'?,U,(Z7>J'6J&UL4$L%!@ % 4 1@$ )M! $!
end